These Numbers Could Change Investor Views For Enliven Therapeutics Inc (NASDAQ: ELVN)
Commodore Capital LP recently announced the acquisition of new stake in Enliven Therapeutics Inc (NASDAQ:ELVN). The institutional investor has increased its shareholding in the Healthcare company by 23.57% to 2.9 million shares with purchase of 0.55 million shares. This fresh investment now brings its stake to 7.04% valued currently at $32.67 million. In addition, Citadel […]
